# Mucosal Immunity Against Neisseria Gonorrhoeae After 4CMenB Vaccination

> **NCT04722003** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 52 (actual)

## Conditions studied

- Gonorrhoea

## Interventions

- **BIOLOGICAL:** Meningococcal Group B Vaccine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04722003
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-01
- **Primary completion:** 2023-10-02
- **Final completion:** 2023-10-02
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2024-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04722003

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04722003, "Mucosal Immunity Against Neisseria Gonorrhoeae After 4CMenB Vaccination". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04722003. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*